And some Open Evidence on ye ole statins and when to use them...
No, statins have never been approved for universal use in all adults over age 50. Statin recommendations have always been based on cardiovascular risk factors and calculated risk, not age alone.
Current US Preventive Services Task Force (USPSTF) guidelines recommend statins for primary prevention in adults aged 40 to 75 years who meet all of the following criteria: (1) presence of at least one cardiovascular disease (CVD) risk factor (dyslipidemia, diabetes, hypertension, or smoking), and (2) a calculated 10-year CVD event risk of ≥10% (B recommendation) or 7.5% to <10% (C recommendation, selective offering). [1] The USPSTF states there is insufficient evidence to recommend initiating statins in adults 76 years or older for primary prevention. [1]
The 2013 ACC/AHA guidelines similarly identified four major statin benefit groups based on clinical trial evidence, but none recommended universal treatment based solely on age. [2] The 2019 ACC/AHA guidelines emphasized risk-based approaches using the Pooled Cohort Equations to estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk, with treatment decisions guided by risk thresholds (≥7.5% to <20% for intermediate risk, ≥20% for high risk) rather than age cutoffs. [3]
The most recent 2026 ACC/AHA dyslipidemia guidelines continue to emphasize individualized decision-making for older adults, noting that time-to-benefit from statins is approximately 2.5 years in adults aged 50-75 years. [4-5] For adults over 75, the guidelines acknowledge limited trial data and recommend shared decision-making that balances potential benefits against risks of polypharmacy, multimorbidity, and patient preferences. [4-5]
No, statins have never been approved for universal use in all adults over age 50. Statin recommendations have always been based on cardiovascular risk factors and calculated risk, not age alone.
Current US Preventive Services Task Force (USPSTF) guidelines recommend statins for primary prevention in adults aged 40 to 75 years who meet all of the following criteria: (1) presence of at least one cardiovascular disease (CVD) risk factor (dyslipidemia, diabetes, hypertension, or smoking), and (2) a calculated 10-year CVD event risk of ≥10% (B recommendation) or 7.5% to <10% (C recommendation, selective offering). [1] The USPSTF states there is insufficient evidence to recommend initiating statins in adults 76 years or older for primary prevention. [1]
The 2013 ACC/AHA guidelines similarly identified four major statin benefit groups based on clinical trial evidence, but none recommended universal treatment based solely on age. [2] The 2019 ACC/AHA guidelines emphasized risk-based approaches using the Pooled Cohort Equations to estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk, with treatment decisions guided by risk thresholds (≥7.5% to <20% for intermediate risk, ≥20% for high risk) rather than age cutoffs. [3]
The most recent 2026 ACC/AHA dyslipidemia guidelines continue to emphasize individualized decision-making for older adults, noting that time-to-benefit from statins is approximately 2.5 years in adults aged 50-75 years. [4-5] For adults over 75, the guidelines acknowledge limited trial data and recommend shared decision-making that balances potential benefits against risks of polypharmacy, multimorbidity, and patient preferences. [4-5]
